Melanie Gaignage

Brussels, BRU 1200, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Antibody-mediated TGF-β1 activation for the treatment of diseases caused by deleterious T cell activity.

Antibody-mediated TGF-β1 activation for the treatment of diseases caused by deleterious T cell activity.

Journal: Cell reports

Published: December 20, 2024

Lactate Dehydrogenase-Elevating Virus Infection Inhibits MOG Peptide Presentation by CD11b+CD11c+ Dendritic Cells in a Mouse Model of Multiple Sclerosis.

Lactate Dehydrogenase-Elevating Virus Infection Inhibits MOG Peptide Presentation by CD11b+CD11c+ Dendritic Cells in a Mouse Model of Multiple Sclerosis.

Journal: International journal of molecular sciences

Published: March 27, 2024

Involvement of Virus-Induced Interferon Production in IgG Autoantibody-Mediated Anemia.

Involvement of Virus-Induced Interferon Production in IgG Autoantibody-Mediated Anemia.

Journal: International journal of molecular sciences

Published: June 29, 2021

Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.

Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice.

Journal: Cancer immunology, immunotherapy : CII

Published: April 19, 2021

Novel antibodies that selectively block mouse IL-12 enable the re-evaluation of the role of IL-12 in immune protection and pathology.

Novel antibodies that selectively block mouse IL-12 enable the re-evaluation of the role of IL-12 in immune protection and pathology.

Journal: European journal of immunology

Published: September 11, 2020

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.

Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.

Journal: Nature communications

Published: January 21, 2020

The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation.

The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation.

Journal: Haematologica

Published: April 12, 2018

Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.

Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.

Journal: European journal of immunology

Published: March 05, 2018

Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.

Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells.

Journal: Immunity, inflammation and disease

Published: December 01, 2016

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Journal: Blood

Published: February 29, 2016

Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.

Self-reactive CD4(+) T cells activated during viral-induced demyelination do not prevent clinical recovery.

Journal: Journal of neuroinflammation

Published: August 20, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026